XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenue:    
Revenue $ 1,503 $ 2,310
Operating expenses:    
Research and development 3,408 3,879
General and administrative 2,010 678
Total operating expenses 5,418 4,557
Operating loss (3,915) (2,247)
Other income and (expenses):    
Bargain purchase gain 6,988
Interest income 5 13
Interest expense (437) (744)
Non-cash interest expense on liability related to sale of future royalties (298)
(Loss) gain on revaluation of financial instruments (3) 182
Foreign exchange gain, net 2
Total other income and (expenses) 6,257 (549)
Net income (loss) before income taxes 2,342 (2,796)
Provision for income taxes 28
Net income (loss) 2,314 (2,796)
Series B and C preferred dividend (339) (710)
Net comprehensive income (loss) attributable to common stockholders $ 1,975 $ (3,506)
Net income (loss) per share – basic (in Dollars per share) $ 0.54 $ (25.84)
Net income (loss) per share - diluted (in Dollars per share) $ 0.49 $ (25.84)
Shares used to compute net income (loss) per share - basic (in Shares) 3,656,360 135,658
Shares used to compute net income (loss) per share - diluted (in Shares) 5,299,751 135,658
Government Contract [Member]    
Revenue:    
Revenue $ 610 $ 2,310
Royalty [Member]    
Revenue:    
Revenue $ 893